Pluri (PLUR) Assets Average (2011 - 2025)
Pluri (PLUR) posted quarterly Assets Average of $32.1 million for Q4 2025, down 3.07% year-over-year from $33.2 million in Q4 2024, and down 11.18% quarter-over-quarter from $36.2 million in Q3 2025.
Pluri (PLUR) Assets Average (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Assets Average for 15 consecutive years, with $32.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average fell 3.07% year-over-year to $32.1 million; the TTM figure through Dec 2025 stood at $32.1 million (down 3.07% YoY), while the FY2025 annual figure was $39.1 million, down 13.41% from the prior year.
- Assets Average fell to $32.1 million in Q4 2025 per PLUR's latest filing, from $36.2 million in the prior quarter.
- Across five years, Assets Average topped out at $88.6 million in Q3 2021 and bottomed at $32.1 million in Q4 2025.
- Historically, Assets Average has averaged $54.6 million across 5 years, with a median of $50.6 million in 2023.
- Annual changes were most pronounced in 2021 — Assets Average surged 174.51% — and 2024, when it tumbled 32.9%.
- Pluri's Assets Average stood at $82.5 million in 2021, then dropped by 27.44% to $59.8 million in 2022, then declined by 28.05% to $43.1 million in 2023, then slipped by 23.0% to $33.2 million in 2024, then decreased by 3.07% to $32.1 million in 2025.
- Business Quant data shows PLUR's Assets Average at $32.1 million in Q4 2025, $36.2 million in Q3 2025, and $38.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.18 Bn | 54.04 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - | 19.82 Bn |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 | 32.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.13 Mn |
| Sep 30, 2025 | 36.18 Mn |
| Jun 30, 2025 | 38.05 Mn |
| Mar 31, 2025 | 34.13 Mn |
| Dec 31, 2024 | 33.15 Mn |
| Sep 30, 2024 | 37.48 Mn |
| Jun 30, 2024 | 37.96 Mn |
| Mar 31, 2024 | 38.98 Mn |
| Dec 31, 2023 | 43.05 Mn |
| Sep 30, 2023 | 47.67 Mn |
| Jun 30, 2023 | 53.52 Mn |
| Mar 31, 2023 | 58.08 Mn |
| Dec 31, 2022 | 59.84 Mn |
| Sep 30, 2022 | 63.91 Mn |
| Jun 30, 2022 | 73.60 Mn |
| Mar 31, 2022 | 80.16 Mn |
| Dec 31, 2021 | 82.47 Mn |
| Sep 30, 2021 | 88.64 Mn |
| Jun 30, 2021 | 86.36 Mn |
| Mar 31, 2021 | 65.72 Mn |